Cempra Competitors and Similar CompaniesClear all

Cempra's competitors and similar companies include Ipsen, Livzon Pharmaceutical Group, CSL Behring and Cadila Pharmaceuticals.
Cempra
Cempra
Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.
Ipsen
Ipsen
Ipsen is a biopharmaceutical company.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
CSL Behring
CSL Behring
CSL Behring is a provider of life-saving medicines.
Cadila Pharmaceuticals
Cadila Pharmaceuticals
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
Founding Date
Founding Date
2006
Founding Date
1929
Founding Date
1985
Founding Date
1904
Founding Date
1951
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Chapel Hill, US HQ
Locations
Boulogne-Billancourt, FR HQ
Algiers, DZ
South Yarra, AU
Wien, AT
Merelbeke, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Locations
King of Prussia, US HQ
Broadmeadows, AU
Parkville, AU
Parkville, AU
Wien, AT
Mechelen, BE
see more
Locations
Bavla, IN HQ
Akaki, ET
Dholka, IN
Chiyoda City, JP
Nairobi, KE
Moskva, RU
Ascot, GB
see more
Employees
Employees
2903% decrease
Employees
5,358
Employees
9,067
Employees
7,5692% decrease
Employees
8,5201% increase
Valuation ($)
Valuation ($)
188.9 m
Valuation ($)
10.2 b
Valuation ($)
4.2 b
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$96.4m (FY, 2018)
Revenue (est.)
€3.7b (FY, 2025)
Revenue (est.)
¥11.7b (FY, 2025)
Revenue (est.)
$7.9b (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$41.1m (FY, 2018)
Cost of goods
€659.1m (FY, 2025)
Cost of goods
¥4.1b (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$55.4m (FY, 2018)
Gross profit
€3.3b (FY, 2025)
Gross profit
¥7.8b (FY, 2025)
Gross profit
$4.5b (FY, 2020)
Gross profit
N/A
Net income
Net income
($157.2m) (FY, 2018)
Net income
€445.1m (FY, 2025)
Net income
¥2.4b (FY, 2025)
Net income
N/A
Net income
N/A

Operating

Trademark Applications
Trademark Applications
N/A
Trademark Applications
N/A
Trademark Applications
3 (Sep, 2023)
Trademark Applications
1 (Dec, 2020)
Trademark Applications
N/A
Trademarks
Trademarks
N/A
Trademarks
N/A
Trademarks
45 (Sep, 2023)
Trademarks
4 (Dec, 2020)
Trademarks
N/A
For sources of this data, please see the company profile

View Company Profiles

Ipsen
HQ
Boulogne-Billancourt, FR
Employees
5,358

Ipsen is a biopharmaceutical company.

View company
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company
CSL Behring
HQ
King of Prussia, US

CSL Behring is a provider of life-saving medicines.

View company
Cadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase

Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.

View company